GENIMMUNE N V has a total of 15 patent applications. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are VACDIAGN BIOTECHNOLOGY CO LTD, LUBITZ WERNER and AVM BIOTECHNOLOGY LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | Australia | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds | |
#5 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Depla Erik | 8 |
#2 | Baker Denise | 5 |
#3 | Buyse Marie-Ange | 4 |
#4 | Van Der Aa Annegret | 3 |
#5 | Bosman Fons | 3 |
#6 | Verheyden Gert | 3 |
#7 | Depraetere Stany | 2 |
#8 | Sette Alessandro | 2 |
#9 | Chesnut Robert | 2 |
#10 | De Schepper Sofie | 2 |
Publication | Filing date | Title |
---|---|---|
EP2222336A2 | Methods and kits for inducing a ctl response using a prime boost regimen | |
EP2201023A2 | Affinity tag | |
WO2009007336A1 | Methods for generating an immune response using dna and a viral vector | |
WO2008145685A1 | Hpv polyepitope constructs and uses thereof | |
WO2008107400A1 | Hcv polyepitope construct and uses thereof | |
EP2004685A2 | Hepatitis c virus neutralizing antibodies | |
AU2002308449B2 | Constructs and methods for expression of recombinant hcv envelope proteins |